Potential role of thioredoxin in immune responses in intestinal lamina propria T lymphocytes

European Journal of Immunology

Volumn 35, Issue 2, 2005, Pages 408-417

  Sido, Bernd ^a   Giese, Thomas ^a   Autschbach, Frank ^a   Lasitschka, Felix ^a   Braunstein, Jutta ^a   Meuer, Stefan C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cytokines; Human; Mucosa; T lymphocytes; Thioredoxin

Indexed keywords

CALCINEURIN; CD2 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 2; MESSENGER RNA; TACROLIMUS; THIOREDOXIN; THIOREDOXIN REDUCTASE;

ARTICLE; AUTOREGULATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTESTINE MUCOSA; LAMINA PROPRIA; MICROENVIRONMENT; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CLONING, MOLECULAR; COLON; CYTOKINES; HUMANS; IMMUNITY, MUCOSAL; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH);

EID: 14744282085     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200424500     Document Type: Article

References (53)

1. Powis, G. and Montfort, W.R., Properties and biological activities of thioredoxins. Annu. Rev. Pharmacol. Toxicol. 2001. 41: 261-295.
2. Tanaka, T., Nakamura, H., Nishiyama, A., Hosoi, F., Masutani, H., Wada, H. and Yodoi, J., Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radic. Res. 2001. 33: 851-855.
3. Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Matsui, H., Hamuro, J., Brown, N., Arai, K., Yokota, T., Wakasugi, H. and Yodoi, J., ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 1989. 8: 757-764.
4. Tagaya, Y., Wakasugi, H., Masutani, H., Nakamura, H, Iwata, S., Mitsui, A., Fujii, S., Wakasugi, N., Tursz, T. and Yodoi, J., Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction. Mol. Immunol. 1990. 27: 1279-1289.
5. Arner, E. S. and Holmgren, A., Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000. 267: 6102-6109.
6. Holmgren, A., Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox Signal. 2000. 2: 811-820.
7. Mustacich, D. and Powis, G., Thioredoxin reductase. Biochem. J. 2000. 346: 1-8.
8. Mitsui, A., Hirakawa, T. and Yodoi, J., Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor (ADF)/human thioredoxin. Biochem. Biophys. Res. Commun. 1992. 186: 1220-1226.
9. Wakasugi, N., Tagaya, Y., Wakasugi, H., Mitsui, A., Maeda, M., Yodoi, J. and Tursz, T., Adult T cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type-I and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin-1 and interleukin-2. Proc. Natl. Acad. Sci. USA 1990. 87: 8282-8286.
10. Furuke, K., Nakamura, H., Hori, T., Iwata, S., Maekawa, M., Inamoto, T., Yamaoka, Y. and Yodoi, J., Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporine A: a new mechanism of immune modulation via redox control. Int. Immunol. 1995. 7: 985-993.
11. Sachi, Y., Hirota, K., Masutani, H., Toda, K., Okamoto, T., Takigawa, M. and Yodoi, J., Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunol. Lett. 1995. 44: 189-193.
12. Tomimoto, H., Akiguchi, I., Wakita, H., Kimura, J., Hori, K. and Yodoi, J., Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gebril brain after transient global ischemia. Brain Res. 1993. 625: 1-8.
13. 2 upon thioredoxin-enriched lens epithelial cells. J. Biol. Chem. 1988. 263: 4984-4990.
14. Schallreuter, K. U. and Wood, J. M., The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem. Biophys. Res. Commun. 1986. 136: 630-637.
15. Nakamura, H., Matsuda, M., Furuke, K., Kitaoka, Y., Iwata, S., Toda, K., Inamoto, T., Yamaoka, Y., Ozawa, K. and Yodoi, J., Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 1994. 42: 75-80.
16. Hayashi, T., Ueno, Y. and Okamoto, T., Oxidoreductive regulation of nuclear factor κB. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 1993. 268: 11380-11388.
17. Matthews, J. R., Wakasugi, N., Virelizier, J. L., Yodoi, J. and Hay, R. T., Thioredoxin regulates the DNA binding activity of NF-κB by reducing of a disulfide bond involving cystein 62. Nucleic Acid Res. 1992. 20: 3821-3830.
18. Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K. and Yodoi, J., AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 1997. 94: 3633-3638.
19. Abate, C., Patel, L., Rauscher, F. J. and Curran, T., Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 1990. 249: 1157-1161.
20. Powis, G., Mustacich, D. and Coon, A., The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 2000. 29: 312-322.
21. Iwata, S., Hori, T., Sato, N., Hirota, K., Sasada, T., Mitsui, A., Hirakawa, T. and Yodoi, J., Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by 1-cystine and glutathione depletion. J. Immunol. 1997. 158: 3108-3117.
22. Powis, G., Kirkpatrick, D. L., Angulo, M. and Baker, A., Thioredoxin redox control of cell growth and death and the effects of inhibitors. Chem. Biol. Interact. 1998. 111-112: 23-34.
23. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K. and Ichijo, H., Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998. 17: 2596-2606.
24. Bertini, R., Howard, O. M., Dong, H. F., Oppenheim, J. J., Bizzarri, C., Sergi, R., Caselli, G., Pagliei, S., Romines, B., Wilshire et al., Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 1999. 189: 1783-1789.
25. Blum, H., Röllinghoff, M. and Gessner, A., Expression and co-cytokine function of murine thioredoxin/adult T cell leukemia-derived factor (ADF). Cytokine 1996. 8: 6-13.
26. Ifversen, P., Zhang, X. M., Ohlin, M., Zeuthen, J. and Borrebaeck, C. A., Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines. Hum. Antib. Hybrid. 1993. 4: 115-123.
27. Iwata, S., Hori, T., Sato, N., Ueda-Taniguchi, Y., Yamabe, T., Nakamura, H., Masutani, H. and Yodoi, J., Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression. J. Immunol. 1994. 152: 5633-5642.
28. Gasdaska, J. R., Berggren, M. and Powis, G., Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ. 1995. 6: 1643-1650.
29. Ericson, M. L., Hörling, J., Wendel-Hansen, V., Holmgren, A. and Rosen, A., Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res. 1992. 11: 201-207.
30. Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E. and Sitia, R., Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 1992. 267: 24161-24164.
31. Schenk, H., Vogt, M., Dröge, W. and Schulze-Osthoff, K., Thioredoxin as a potent costimulus of cytokine expression. J. Immunol. 1996. 156: 765-771.
32. Gasdaska, J. R., Gasdaska, P. Y., Gallegos, A. and Powis, G., Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue. Genomics 1996. 37: 257-259.
33. Sido, B., Braunstein, J., Breitkreutz, R., Herfarth, C. and Meuer, S. C., Thiol-mediated redox regulation of intetstinal lamina propria T lymphocytes. J. Exp. Med. 2000. 192: 907-912.
34. Autschbach, F., Schürmann, G., Qiao, L., Merz, H., Wallich, R. and Meuer, S. C., Cytokine messenger-RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Archiv 1995. 426: 51-60.
35. Rugtveit, J., Brandtzaeg, P., Halstensen, T. S., Fausa, O. and Scott, H., Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994. 35: 669-674.
36. Burgio, V. L., Fais, S., Boirivant, M., Perrone, A. and Pallone, F., Peripheral monocyte and naive T cell recruitment and activation in Crohn's disease. Gastroenterology 1995. 109: 1029-1038.
37. Braunstein, J., Autschbach, F., Sido, B., Nebl, G., Schröder, A., Samstag, Y. and Meuer, S. C., Insensitivity towards inhibition by cyclosporine A, rapamycin, and tacrolimus in human lamina propria T lymphocytes. In Stallmach, A., Zeitz, M., MacDonald, T. T., Strober, W. and Lochs, H. (Eds.) Induction and Modulation of Gastrointestinal Inflammation. Kluwer Academic Publishers, Dordrecht 1999, pp 289-296.
38. Braunstein, J., Qiao, L., Autschbach, F., Schürmann, G. and Meuer, S., T cells of the human intestinal lamina propria are high producers of interleukin-10. Gut 1997. 41: 215-220.
39. Taniguchi, Y., Taniguchi-Ueda, Y., Mori, K. and Yodoi, J., A novel promotor sequence is involved in the oxidative stress-induced expression of the adult T cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res. 1996. 14: 2746-2752.
40. Gromer, S., Arscott, L. D., Williams, C. H. and Schirmer, R. H., Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J. Biol. Chem. 1998. 32: 20096-20101.
41. Bogumil, R., Namgaladze, D., Schaarschmidt, D., Schmachtel, T., Hellstern, S., Mutzel, R. and Ullrich, V., Inactivation of calcineurin by hydrogen peroxide and phenylarsine oxide. Evidence for a dithiol-disulfide equilibrium and implications for redox regulation. Eur. J. Biochem. 2000. 267: 1407-1415.
42. Qiao, L., Braunstein, J., Golling, M., Schürmann, G., Autschbach, F., Möller, P. and Meuer, S. C., Differential regulation of human T cell responsiveness by mucosal versus blood monocytes. Eur. J. Immunol. 1996. 26: 922-927.
43. Harper, R., Wu, K., Chang, M. M., Yoneda, K., Pan, R., Reddy, S. P. and Wu, R., Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione. Am. J. Respir. Cell. Mol. Biol. 2001. 25: 178-185.
44. Galter, D., Mihm, S. and Dröge, W., Distinct effects of glutathione disulfide on the nuclear transcription factor κB and the activator protein-1. Eur. J. Biochem. 1994. 221: 639-648.
45. Suzuki, Y. J., Mizuno, M., Tritschler, H. J. and Packer, L., Redox regulation of NF-κB DNA binding activity by dihydrolipoate. Biochem. Mol. Biol. 1995. 36: 241-246.
46. Bannister, A. J., Cook, A. and Kouzarides, T., In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 1991. 6: 1243-1250.
47. Frame, M. C., Wilkie, N. M., Darling, A. J., Chudleigh, A., Pintzas, A., Lang, J. C. and Gillespie, D. A., Regulation of AP-1/DNA complex formation in vitro. Oncogene 1991. 6: 205-209.
48. Carballo, M., Marquez, G., Conde, M., Martin-Nieto, J., Monteseirin, J., Conde, J., Pintado, E. and Sobrino, F., Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J. Biol. Chem. 1999. 274: 93-100.
49. Nilsson, J., Soderberg, O., Nilsson, K. and Rosen, A., Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. Blood 2000. 95: 1420-1426.
50. Yoshida, S., Katoh, T., Tetsuka, T., Uno, K., Matsui, N. and Okamoto, T., Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J. Immunol. 1999. 163: 351-358.
51. Zeitz, M., Quinn, T. C., Graeff, A. S., Schwarting, R. and James, S. P., Oral administration of cyclosporin does not prevent expansion of antigen-specific, gut-associated, and spleen lymphocyte populations during Chlamydia trachomatis proctitis in nonhuman primates. Dig. Dis. Sci. 1989. 34: 585-595.
52. Schenk, H., Klein, M., Erdbrugger, W., Dröge, W. and Schulze-Osthoff, K., Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappaB and AP-1. Proc. Natl. Acad. Sci. USA 1994. 91: 1672-1676.
53. Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A. F., Stein, H. and Mason, D. Y., Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984. 32: 219-229.